mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
1 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.001 |
1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00095 |
1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.00082 |
1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00067 |
1 |